Bachem Holding AG (BANB.SW)
- Previous Close
79.90 - Open
80.00 - Bid --
- Ask --
- Day's Range
79.25 - 81.10 - 52 Week Range
53.95 - 105.60 - Volume
41,232 - Avg. Volume
89,561 - Market Cap (intraday)
6.08B - Beta (5Y Monthly) 0.69
- PE Ratio (TTM)
54.07 - EPS (TTM)
1.50 - Earnings Date Jul 25, 2024
- Forward Dividend & Yield 0.80 (0.99%)
- Ex-Dividend Date Apr 26, 2024
- 1y Target Est
70.80
Bachem Holding AG, together with its subsidiaries, provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide. The company engages in the development, production, and regulatory support of peptide active pharmaceutical ingredients, such as peptide and oligonucleotide new chemical entities (NCEs). It also offers commercial NCEs and generics; and project management, quality and regulatory, analytical, good manufacturing practice production, research grade production, and supply and vertical integration services. Bachem Holding AG was founded in 1971 and is headquartered in Bubendorf, Switzerland.
www.bachem.comRelated News
Performance Overview: BANB.SW
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: BANB.SW
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: BANB.SW
Valuation Measures
Market Cap
6.08B
Enterprise Value
5.78B
Trailing P/E
54.07
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
10.53
Price/Book (mrq)
4.60
Enterprise Value/Revenue
10.02
Enterprise Value/EBITDA
34.12
Financial Highlights
Profitability and Income Statement
Profit Margin
19.38%
Return on Assets (ttm)
5.27%
Return on Equity (ttm)
8.98%
Revenue (ttm)
577.32M
Net Income Avi to Common (ttm)
111.86M
Diluted EPS (ttm)
1.50
Balance Sheet and Cash Flow
Total Cash (mrq)
298.53M
Total Debt/Equity (mrq)
0.03%
Levered Free Cash Flow (ttm)
-199.8M
Research Analysis: BANB.SW
Analyst Price Targets
Fair Value
No Fair Value available for this ticker
Company Insights: BANB.SW
BANB.SW does not have Company Insights